VIET HUY MAKES ITS MARK AT THE ANNUAL SCIENTIFIC CONFERENCE ON CANCER PREVENTION AND CONTROL - HUE 2025
Accompanying this event, Viet Huy was pleased to introduce modern molecular diagnostic solutions. Our booth was honored to welcome many doctors and medical staff, who visited and exchanged professional insights.
VIET HUY Introduces Its Featured Solutions at the Conference
Viet Huy presented three groups of representative oncology solutions, which received special attention from experts. Among them, the cancer targeted therapy marker testing solution from EntroGen (USA) became a standout highlight, helping to bring personalized medicine into clinical practice.
In addition, the solutions for pharmacogenetic testing and cervical cancer screening also attracted attention. These solutions help personalize treatment regimens and support risk stratification, minimizing unnecessary invasive interventions for patients.
Single-Gene/Multi-Gene Mutation Testing in Cancer
Helps personalize treatment regimens and increases patients' chances of success.
Targeted Therapy Marker Testing Solution
Helps doctors select the treatment regimen with the highest probability of success for each patient. This solution has broad applications, detecting most of the important markers recommended in NCCN & ESMO guidelines for many types of cancer, such as lung, colorectal, thyroid and prostate cancer, and hematologic malignancies.
A Diverse Range of Tests
EntroGen offers a comprehensive product portfolio, from single-gene to multi-gene (panel) tests, using both Real-Time PCR and NGS technologies. The tests can be performed on many different sample types, including tissue, liquid biopsy and fine-needle aspiration (FNA) samples.
Rigorous Quality Control
The EntroGen solution offers an optional quality control (QC) step for input DNA using real-time PCR, helping to ensure sample quality and minimize false negatives.
Pharmacogenetic Testing (CYP2C19, CYP2C9-VKORC1)
Helps doctors adjust dosages or choose appropriate drug regimens, especially for patients who need to take multiple drugs in combination.
Cervical Cancer Screening With PAX1 & JAM3 Methylation
Helps stratify risk and minimize unnecessary invasive interventions without missing high-risk patients (CIN2+ lesions).
Through the event, we had the opportunity to listen to and share with experts and doctors, working together to find effective and sustainable diagnostic and treatment solutions. Viet Huy believes there will always be a suitable solution for every patient and every healthcare facility.
Viet Huy sincerely thanks the doctors and experts who visited our booth and shared valuable professional exchanges. We believe that no single solution fits all, but there will always be an optimal solution for each patient. Viet Huy's mission is to serve as a bridge, bringing modern diagnostic solutions into clinical practice for the shared goal of improving the quality of cancer treatment in Vietnam.
Our journey continues. We look forward to seeing you at upcoming events to keep up with new advances together and spread hope to cancer patients.
Other Events
Viet Huy at the Can Tho Oncology Conference (CACO 14): Affirming the Role of Molecular Biology in Precision Medicine
The 14th Can Tho Oncology Conference (CACO 14) was successfully held on Sep 25-26 at the Sheraton Can Tho Hotel. At the event, Viet Huy proudly presented a comprehensive range of molecular biology solutions, which became a focal point of discussion and attracted great interest from the medical community.
PATHOLOGY CONFERENCE - VIET HUY MAKES ITS MARK
On Apr 24, 2025, at the Scientific Conference on Pathology organized by Military Hospital 103, VIET HUY not only attended but also left a memorable mark. Over nearly 20 years of partnering with the healthcare sector, we have come to understand that each conference like this is not only a place to update knowledge but also a valuable opportunity to share our passion for solutions that help improve the quality of laboratory testing in Vietnam.
Viet Huy introduces IVD testing solutions at Ninh Thuan Provincial General Hospital
On Jan 9, 2025, VIET HUY Technological Scientific Equipment Co., Ltd, in collaboration with BM Group Joint Stock Company, held an in-depth knowledge-sharing session at Ninh Thuan General Hospital on the topic: "Real-time PCR testing solutions in the diagnosis of infectious diseases and cancer"